Literature DB >> 31178072

Evaluation of intraocular pressure in the first 24hours after micropulse laser trabeculoplasty in eyes with pseudoexfoliation glaucoma.

O E Makri1, D Pagoulatos1, K Kagkelaris1, P Plotas1, C D Georgakopoulos2.   

Abstract

PURPOSE: To evaluate the immediate 24-hour effect on intraocular pressure (IOP) of a single session of micropulse laser trabeculoplasty (MLT) in patients with pseudoexfoliation glaucoma (PEXG). PATIENTS AND METHODS: In this single-center, one-arm, prospective study, patients with PEXG on prostaglandin analogue monotherapy with inadequate IOP control were treated with 360-degree 532nm MLT. Intraocular pressure was evaluated at 1, 4, 8, 12 and 24hours after MLT. Twenty-three eyes of eighteen patients (10 male, 8 female) were enrolled in the study.
RESULTS: The mean age of the patients was 71.83±6.51 years, and the mean IOP prior to MLT was 20.61±1.8mmHg. The mean IOP was reduced by 2.17±3.31mmHg, 2.69±3.85mmHg, 0.87±3.02mmHg, 2.13±2.8mmHg and -0.87±3mmHg at 1, 4, 8 and 24hours after MLT, respectively. At 4 and 12hours after MLT, the mean IOP was statistically significantly lower compared to the pre-MLT IOP (P=0.043 and P=0.021 respectively). No eye experienced an IOP spike≥5mmHg during the first 24hours after MLT. CONCUSION: Treatment with MLT in PEXG eyes did not result in any significant, potentially dangerous IOP spikes during the first 24hours after MLT.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glaucome pseudo-exfoliatif; Intraocular pressure spikes; Micropulse laser trabeculoplasty; Pics d’hypertonie oculaire; Pseudoexfoliation glaucoma; Trabéculoplastie au laser micropulsé

Mesh:

Year:  2019        PMID: 31178072     DOI: 10.1016/j.jfo.2019.05.008

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results.

Authors:  Yuting Yang; Xinting Huang; Sheng Liao; Feng Zhang; Jingming Shi; Xuanchu Duan; Ke Liu
Journal:  BMC Ophthalmol       Date:  2022-06-04       Impact factor: 2.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.